(S,S,S)-N,N'-(1,4-phenylenebis-(methylene))bis(1-(5-((S)-1-((S)-3-methyl-2-((S)-2-(methylamino)-propanamido)butanoyl)pyrrolidin-2-yl)pyridin-3-yl)-1H-indole-4-carboxamide) | 1381992-70-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (S,S,S)-N,N'-(1,4-phenylenebis-(methylene))bis(1-(5-((S)-1-((S)-3-methyl-2-((S)-2-(methylamino)-propanamido)butanoyl)pyrrolidin-2-yl)pyridin-3-yl)-1H-indole-4-carboxamide)
• 英文别名: N,N'-(1,4-phenylenebis(methylene))bis(1-(5-((S)-1-((S)-3-methyl-2-((S)-2-(methylamino)propanamido)butanoyl)pyrrolidin-2-yl)pyridin-3-yl)-1H-indole-4-carboxamide)；1-[5-[(2S)-1-[(2S)-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]pyrrolidin-2-yl]pyridin-3-yl]-N-[[4-[[[1-[5-[(2S)-1-[(2S)-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]pyrrolidin-2-yl]pyridin-3-yl]indole-4-carbonyl]amino]methyl]phenyl]methyl]indole-4-carboxamide
• CAS: 1381992-70-6
• 化学式: C₆₂H₇₄N₁₂O₆
• 分子量: 1083.35
• InChiKey: AMBGBHRVMYXOCA-AFXPEWIHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.9
• 重原子数：
  80
• 可旋转键数：
  20
• 环数：
  9.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  217
• 氢给体数：
  6
• 氢受体数：
  10

文献信息

• [EN] DIMERIC IAP INHIBITORS<br/>[FR] INHIBITEURS IAP DIMÉRIQUES
  申请人：NOVARTIS AG

  公开号：WO2012080271A1

  公开（公告）日：2012-06-21

  The present invention provides compounds of formula M-L-M' (where M and M' are each independently a monomeric moiety of Formula (I) and L is a linker). The dimeric compounds have been found to be effective in promoting apoptosis in rapidly dividing cells. (I)

  本发明提供了公式M-L-M'的化合物（其中M和M'分别独立地是公式（I）的单体基团，L是连接基团）。已发现二聚化合物在促进快速分裂细胞凋亡方面具有有效性。（I）
• DIMERIC IAP INHIBITORS
  申请人：Chen Zhuoliang

  公开号：US20130309247A1

  公开（公告）日：2013-11-21

  The present invention provides compounds of formula M-L-M′ (where M and M′ are each independently a monomeric moiety of Formula (I) and L is a linker). The dimeric compounds have been found to be effective in promoting apoptosis in rapidly dividing cells. (I)

  本发明提供了公式M-L-M'的化合物（其中M和M'分别独立地是公式（I）的单体基团，L是连接剂）。已发现二聚化合物在促进快速分裂细胞的凋亡方面具有有效性。 (I)
• BIOMARKERS FOR IAP INHIBITOR THERAPY
  申请人：Porter Dale

  公开号：US20150105434A1

  公开（公告）日：2015-04-16

  A method of selecting a subject having cancer for treatment with an IAP inhibitor.
• COMPOUNDS FOR TREATING OR INHIBITING RECURRENCE OF ACUTE MYELOID LEUKEMIA
  申请人：Flash Therapeutics, LLC

  公开号：US20210299128A1

  公开（公告）日：2021-09-30

  This invention relates to compounds for treating acute myeloid leukemia or inhibiting recurrence of acute myeloid leukemia and for inhibiting growth of and/or killing leukemic stem cells.
• US8993523B2
  申请人：——

  公开号：US8993523B2

  公开（公告）日：2015-03-31